10x Genomics
(NASDAQ) TXG
10x Genomics Financials at a Glance
Market Cap
$5.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$638.78M
Net Income (TTM)
-$22.66M
EPS (TTM)
-$0.17
P/E Ratio
-247.13
Dividend
$0.00
Beta (Volatility)
2.04 (High)
Dividend
$0.00
Beta (Volatility)
2.04 (High)
Price
$42.89
Volume
738.584
Open
$38.33
Price
$42.89
Volume
738.584
Open
$38.33
Previous Close
$43.10
Daily Range
$38.33 - $43.10
52-Week Range
$11.16 - $43.10
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
2.04 (High)
Price
$42.89
Volume
738.584
Open
$38.33
Previous Close
$43.10
Daily Range
$38.33 - $43.10
52-Week Range
$11.16 - $43.10
Estimated Earnings Date
Aug 6, 2026
TXG News
TXG: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 10x Genomics
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
1,178
CEO
Serge Saxonov, PhD
Website
www.10xgenomics.comHeadquarters
Pleasanton, CA 94588-3260, US
TXG Financials
Key Financial Metrics (TTM)
Gross Margin
69.60%
Operating Margin
-6.06%
Net Income Margin
-3.55%
Return on Equity
-2.86%
Return on Capital
-11.62%
Return on Assets
-2.23%
Earnings Yield
-0.40%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$5.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
126.96M
Volume
738.584
Avg. Volume
3.08M
Financials (TTM)
Gross Profit
$444.61M
Operating Income
-$38.70M
EBITDA
$93.30M
Operating Cash Flow
$127.82M
Capital Expenditure
-$5.64M
Free Cash Flow
$122.18M
Cash & ST Invst.
$539.85M
Total Debt
$81.39M
10x Genomics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$150.84M
-2.6%
Gross Profit
$106.18M
+0.7%
Gross Margin
70.39%
N/A
Market Cap
$5.47BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$4.19M
N/A
Employees
1,306
N/A
Net Income
-$13.47M
+60.8%
EBITDA
-$937.00K
+96.0%
Quarterly Fundamentals
Total Cash
$539.85M
+26.5%
Total Debt
$81.39M
+1.6%
Accounts Receivable
$56.14M
+6.8%
Inventory
$53.49M
-28.4%
Long Term Debt
$70.06M
-0.8%
Short Term Debt
$11.33M
+20.0%
Return on Assets
-2.23%
N/A
Return on Invested Capital
-4.29%
N/A
Free Cash Flow
$24.52M
-24.4%
Operating Cash Flow
$26.12M
-24.0%